Journal of Medical Toxicology

, Volume 10, Issue 1, pp 15–18 | Cite as

Electronic Pharmacopoeia: A Missed Opportunity for Safe Opioid Prescribing Information?

  • Jeff Lapoint
  • Jeanmarie Perrone
  • Lewis S. Nelson
Toxicology Investigation


Errors in prescribing of dangerous medications, such as extended release or long acting (ER/LA) opioid forlmulations, remain an important cause of patient harm. Prescribing errors often relate to the failure to note warnings regarding contraindications and drug interactions. Many prescribers utilize electronic pharmacopoeia (EP) to improve medication ordering. The purpose of this study is to assess the ability of commonly used apps to provide accurate safety information about the boxed warning for ER/LA opioids. We evaluated a convenience sample of six popular EP apps available for the iPhone and an online reference for the presence of relevant safety warnings. We accessed the dosing information for each of six ER/LA medications and assessed for the presence of an easily identifiable indication that a boxed warning was present, even if the warning itself was not provided. The prominence of precautionary drug information presented to the user was assessed for each app. Provided information was classified based on the presence of the warning in the ordering pathway, located separately but within the prescribers view, or available in a separate screen of the drug information but non-highlighted. Each program provided a consistent level of warning information for each of the six ER/LA medications. Only 2/7 programs placed a warning in line with dosing information (level 1); 3/7 programs offered level 2 warning and 1/7 offered level 3 warning. One program made no mention of a boxed warning. Most EP apps isolate important safety warnings, and this represents a missed opportunity to improve prescribing practices.


Opioids Medication safety Prescribing Pharmacopoeia Boxed warning 


  1. 1.
    Paulozzi LG, Jones CM, Mack KA, Rudd RA (2011) Vital signs: overdoses of prescription opioid pain relievers –- United States, 1999–2008. MMWR Morb Mortal Wkly Rep 60:1487–1492Google Scholar
  2. 2.
    Okie S (2011) A flood of opioids, a rising tide of deaths. N Engl J Med 363(21):1981–1985CrossRefGoogle Scholar
  3. 3.
    Rich BA, Webster LR (2011) A review of forensic implications of opioid prescribing with examples from malpractice cases involving opioid-related overdose. Pain Med 12(Suppl 2):S59–S65PubMedCrossRefGoogle Scholar
  4. 4.
    Denison Davies E, Schneider F, Childs S et al (2011) A prevalence study of errors in opioid prescribing in a large teaching hospital. Int J Clin Pract 65(9):923–929PubMedCrossRefGoogle Scholar
  5. 5.
    Wright A, Feblowitz J, Phansalkar S et al (2012) Preventability of adverse drug events involving multiple drugs using publicly available clinical decision support tools. Am J Health Syst Pharm 69(3):221–227PubMedCrossRefGoogle Scholar
  6. 6.
    Logan P, Collins S (2009) PDA survey of medical residents: e-books before e-mail. J Can Health Libr Assoc 30(1):3–10CrossRefGoogle Scholar
  7. 7.
    Garritty C, El Emam K (2006) Who’s using PDAs? Estimates of PDA use by health care providers: a systematic review of surveys. J Med Internet Res 8(2):e7PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Epocrates Accessed September 13, 2013
  9. 9.
    Dy SM, Shore AD, Hicks RW, Morlock LL (2007) Medication errors with opioids: results from a national reporting system. J Opioid Manag 3(4):189–194PubMedGoogle Scholar
  10. 10.
    Institute for Safe Medication Practices. Ongoing, preventable fatal events with fentanyl transdermal patches are alarming! Accessed August 11, 2012
  11. 11.
    Webster LR, Cochella S, Dasgupta N et al (2011) An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 12(Suppl 2):S26–S35PubMedCrossRefGoogle Scholar
  12. 12.
    Apple iTunes Accessed December 11, 2012
  13. 13.
    Isaac T, Weissman JS, Davis RB, Massagli M, Cyrulik A, Sands DZ, Weingart SN (2009) Overrides of medication alerts in ambulatory care. Arch Intern Med 169(3):305–311PubMedCrossRefGoogle Scholar
  14. 14.
    Jellinek SP, Cohen V, Stansfield L, Likourezos A, Sable KN (2010) A survey of drug information references emergency medicine clinicians utilize for prescribing in pregnant patients. Ann Pharmacother 44(3):456–461PubMedCrossRefGoogle Scholar
  15. 15.
    Slight SP, Nanji KC, Seger DL, Cho I, Volk LA, Bates DW (2013) Overrides of clinical decision support alerts in primary care clinics. Stud Health Technol Inform 192:923PubMedGoogle Scholar
  16. 16.
    Dunn KM, Saunders KW, Rutter CM et al (2010) Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 152:85–92PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Nelson LS, Perrone J (2012) Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS). JAMA 308(5):457–458PubMedCrossRefGoogle Scholar

Copyright information

© American College of Medical Toxicology 2013

Authors and Affiliations

  • Jeff Lapoint
    • 1
  • Jeanmarie Perrone
    • 2
  • Lewis S. Nelson
    • 3
  1. 1.Department of Emergency MedicineSouthern California Permanente Medical GroupSan DiegoUSA
  2. 2.Department of Emergency Medicine, Division of Medical ToxicologyPerelman School of Medicine at the University of PennsylvaniaPhiladelphiaUSA
  3. 3.Department of Emergency Medicine, Director, Fellowship in Medical ToxicologyNew York University School of MedicineNew YorkUSA

Personalised recommendations